Skip to main content
Log in

Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse

  • Original Articles
  • Thiols, Alkylating Agents, Skin Toxicity, Thiosulfate
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The highly vesicant nature of the alkylating anticancer agent mechlorethamine (HN2, or nitrogen mustard) requires careful i. v. technique during its administration. Skin toxicity due to HN2 extravasation is severe and typically prolonged over several months. Mouse skin toxicity studies were carried out to find a local antidote to decrease the severity of tissue damage by this agent. Intradermal (i.d.) HN2 (0.005–0.5 mg) caused dose-dependent skin ulcers in the mouse. Isotonic sodium thiosulfate Na2S2O3 (0.167 M) or hypertonic (0.34 M) Na2S2O3 (0.05 ml) given immediately after HN2 significantly reduced the mean HN2 ulceration area and the total time of ulceration. Ineffective local HN2 antidotes included hyaluronidase, hydrocortisone, and sodium chloride, all given i.d. Topical applications of DMSO, cold, and heat were also ineffective. Sodium thiosulfate is believed to chemically neutralize reactive mechlorethamine-alkylating species and thus decrease skin toxicity. Thiosulfate dosing studies showed that a molar excess of at least 200:1 (Na2S2O3:HN2) was required for significant antidotal activity. If thiosulfate treatment was delayed 4–24 h after HN2, no antidotal effects were obtained. We conclude that sodium thiosulfate can decrease the severity of local tissue damage caused by HN2. It should be considered the antidote of choice in the setting of clinical HN2 extravasations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bonadonna G, Karnofsky DA (1965) Protection studies with sodium thiosulfate against methyl bis (B-chloroethyl) amince hydrochloride (HN2) and its ethyleimmonium derivative. Clin Pharmacol Ther 6(1): 50–64

    Google Scholar 

  2. Calabresi P, Parks RE (1975) Alkylating agents, antimetabolites, hormones, and other antiproliferative agents. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 1254–1262

    Google Scholar 

  3. Chait LA, Dinner MI (1975) Ulceration caused by cytotoxic drugs. S Afr Med J 49: 1935–1936

    Google Scholar 

  4. Dorr RT, Alberts DS, Chen HSG (1980) Experimental model of doxorubicin extravasation in the mouse. J Pharmacol Methods 4(4): 321–334

    Google Scholar 

  5. Dorr RT, Alberts DS, Stone A (1985) Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep 69: 431–437

    Google Scholar 

  6. Gilman A (1963) The initial clinical trial of nitrogen mustard. Am J Surg 105: 574–578

    Google Scholar 

  7. Goodman L, Wintrobe M, Dameshek W, Goodman MJ, Gilman A, McLennan MT (1946) Nitrogen mustard therapy. J Am Med Assoc 132(3): 126–132

    Google Scholar 

  8. Hatiboglu I, Mihich E, Moore GE, Nichol CA (1962) Use of sodium thiosulfate as a neutralizing agent during regional administration of nitrogen mustard: An experimental study. Ann Surg 156(6): 994–1001

    Google Scholar 

  9. Litwins J, Boyd JJ, Greenwald L (1943) Action of sodium thiosulfate on blood. Exp Med Surg 1: 252–259

    Google Scholar 

  10. Merck, Sharpe and Dohme Company, Mustargen official prescribing information. (1985) Physician desk reference, 39th edn. Medical Economics Co, Oradell, NJ, pp 1337–1339

    Google Scholar 

  11. Nie NH, Hill CH, Jenkins JG, Steinbrenner K, Bent DH (1975) Statistical packages for the social services. McGraw-Hill, New York, pp 422–430

    Google Scholar 

  12. Ogston A, Holiday J, Philpot J, Stocken LA (1984) The replacement reactions of beta dichlorethyl sulphide and of some analogous in aqueous solution: The isolation of beta chloro beta hydroxyl diethyl sulphide. Trans Faraday Soc 44: 45

    CAS  PubMed  Google Scholar 

  13. Owen OE, Dellatorre DL, Van Scott EJ, Cohen MR (1980) Accidental intramuscular injection of mechlorethamine. Cancer 45: 2225–2226

    Google Scholar 

  14. Owens G, Hatiboglu I (1961) Clinical evaluation of sodium thiosulfate, a systemic neutralizer of nitrogen mustard. Ann Surg 154: 895–897

    Google Scholar 

  15. Shea M, Koziol JA, Howell SB (1984) Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35(3): 419–425

    Google Scholar 

  16. Van Scott EJ, Kimanson JD (1973) Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Cancer 32: 18–30

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Public Health Service Grants CA-31078, CA-23074, and CA-17094 from the National Cancer Institute; National Institute of Health, Department of Health and Human Services, Bethesda, MD

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dorr, R.T., Soble, M. & Alberts, D.S. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother. Pharmacol. 22, 299–302 (1988). https://doi.org/10.1007/BF00254235

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254235

Keywords

Navigation